Evidence map›Paper›PMID 32729494›Full record

ReviewBiosensors & bioelectronics2020

Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis.

Supratim Mahapatra, Pranjal Chandra

Abstract readReview
In one paragraph

Review in Biosensors & bioelectronics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. FRET-based hACE2 receptor mimic peptide conjugated nanoprobe for simple detection of SARS-CoV-2.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2022
    Article
  8. Article
  9. Review
  10. Rapid diagnosis of COVID-19RSC advances · 2022
    Review
  11. Visual naked-eye detection of SARS-CoV-2 RNA based on covalent organic framework capsules.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2022
    Article
  12. Recent Progress on Rapid Lateral Flow Assay-Based Early Diagnosis of COVID-19.Frontiers in bioengineering and biotechnology · 2022
    Review
  13. Article
  14. Perspectives on electrochemical biosensing of COVID-19.Current opinion in electrochemistry · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Supratim MahapatraLaboratory of Bio-Physio Sensors and Nanobioengineering, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi, Uttar Pradesh 221005, India.
Pranjal ChandraLaboratory of Bio-Physio Sensors and Nanobioengineering, School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, Varanasi, Uttar Pradesh 221005, India. Electronic address: pranjalchandra@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recent outbreak of the coronavirus disease (COVID-19) has left the world clueless. As the WHO declares this new contagion as a pandemic on the 11

Indexed as

Lab-On-A-Chip DevicesPoint-of-Care TestingAnimalsAntibodies, ImmobilizedBetacoronavirusBiomarkersBiosensing TechniquesClustered Regularly Interspaced Short Palindromic RepeatsCoronavirus InfectionsCOVID-19Equipment DesignHumansImmunoassayNanostructuresPandemicsPneumonia, ViralAntibodies, ImmobilizedBiomarkersClinical diagnosisCOVID-19ImmunoassayPoint of careRT-PCRSARS-CoV-2Serological tests

Identifiers

PMID32729494
PMCPMC7834411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.